Results for tag: "Invokamet"

Invokamet is a brand of Endocrine and Metabolic Disorders Drugs used to treat type 2 diabetes. It is a combination of two drugs, metformin and canagliflozin, which work together to reduce blood sugar levels. Invokamet is taken orally and is available in both tablet and liquid form. It is used to help control blood sugar levels in adults with type 2 diabetes, and can also be used in combination with other diabetes medications. Invokamet is designed to help reduce the risk of serious complications associated with diabetes, such as heart attack, stroke, and kidney disease. The Invokamet market is highly competitive, with many companies offering similar products. Some of the major players in the market include Merck, Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca. These companies offer a variety of products, including tablets, liquids, and injectables, to meet the needs of patients with type 2 diabetes. Show Less Read more